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Abstract
Background: Breast cancer is very rare in men, and the occurrence of occult breast cancer which
present axillary metastasis as the first manifestation is even rarer in men.
Case presentation: We report a 72-year-old male Han-Chinese patient who presented axillary
metastasis as the first manifestation of breast cancer and got correctly diagnoses by histological
examination. He underwent modified radical mastectomy and axillary dissection on 11 Apr 2006.
The histopathologic examination showed that no tumor focus was found in his breast tissue, but
two out of fifteen of axillary lymph nodes were invaded by infiltrating ductal carcinoma. The IHC
stain showed that estrogen receptor (ER) and progestin receptor (PR) were negative, Human
epidermal receptor (HER-2) oncoprotein (+++), P53 protein expressed (+++), Bcl-2 oncoprotein
(+++), nm23 protein (++), proliferating cell nuclear antigen (PCNA) (+++) and multidrug-
resistance protein (MRP) (++). After operation, he did not receive endocrine therapy,
chemotherapy and radiotherapy because of his senility. He is alive without any residual or
metastasis disease 29 months after being diagnosed.
Conclusion: This is the first case in our hospital that presents axillary metastases as the first
manifestation of male breast cancer.
Background
Breast cancer is very rare in men, accounting for less than
1% of all breast cancers and less than 1% of all cancers in
men [1,2]; and the occurrence of occult breast cancer is
even rarer in men [3]. We report a 72-year-old male Han-
Chinese patient with occult breast cancer who was diag-
nosed by histological examination and Immunohisto-
chemical (IHC) stain. It is the first male case of our
hospital that presents axillary metastasis as the first mani-
festation of occult breast cancer.
Case presentation
A 72-year-old male Han-Chinese patient presented with a
painless and enlarged lymph node in the right axillary for
about 6 months without any palpable breast mass (Figure
1). His history showed that no evidence of liver diseases;
no medication had been taken, and in particular, there
was no history of hormonal treatment. The axillary lymph
node biopsy showed that it was invaded by infiltrating
ductal carcinoma (IDC) which was in suspect metasta-
sized from breast. The patient was kept in hospital and
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took a series of physical, X-ray and ultrasonic examina-
tions. But no other focuses were found in body. The result
of the hepatic function test was natural. The biopsy slice
was circulated and opinions were sought from fellows of
other hospitals. Then, the pathologists came to a conclu-
sion that the male patient was a case with occult breast
cancer. The patient underwent a modified radical mastec-
tomy and axillary dissection on 11 April 2006. The histo-
logical examination of paraffin sections stained with
hematoxylin and eosin (HE) revealed that no tumor focus
was found in breast, but two out of fifteen of axillary
lymph nodes were invaded by IDC. The histological
examination showed the lymph tissue massively and dif-
fusively infiltrated with big and relatively round tumor
cells that are tightly cohesive and displayed round-to-
ovoid nuclei and a thin rim of cytoplasm with an occa-
sional intracytoplasmic lumen (Figure 2). The IHC stain
(Figure 3, 4, 5, 6, 7, 8) showed estrogen receptor (ER) and
progestin receptor (PR) were negative, P53 protein
expressed (+++), proliferating cell nuclear antigen
(PCNA) (+++), Bcl-2 oncoprotein (+++), nm23 protein
(++), multidrug-resistance protein (MRP) (++), Human
epidermal receptor (HER-2) oncoprotein (+++). This
patient did not receive endocrine therapy, chemotherapy
and radiotherapy after operation. He is alive without any
residual or metastasis disease 29 months after being diag-
nosed; and he is still in follow-up.
Discussion
Breast cancer is very rare in men. Epidemiological studies
showed that the rate of male breast cancer is 0.5%–1%, in
most western countries, and 6% or more in Tanzania and
in Central Africa [1,2]. The reasons for this geographic var-
iability remain unclear. Recent epidemiologic data sug-
gested that the incidence of male breast cancer has been
steadily increasing [4]. However, the pathogenesis of male
breast cancer is still unclear. The epidemiologic risk fac-
tors may include prostate cancer and its endocrine ther-
apy, gynecomastia, occupational exposures (e.g.,
electromagnetic fields, polycyclic aromatic hydrocarbons,
and high temperatures), dietary factors (e.g., meat intake,
fruit and vegetable consumption), and alcohol intake.
External photography of patient's chest Figure 1
External photography of patient's chest. showing 
enlarged lymph node in the right axillary after biopsy, with-
out palpable breast mass.
Metastatic IDC in axillary lymph node Figure 2
Metastatic IDC in axillary lymph node. the structure of 
lymph node which was invaded by metastatic IDC has been 
destroyed. Big, relatively round tumor cells can be seen 
invading the lymph node tissue (HE stain, original magnifica-
tion ×200).
IHC stain of HER-2 oncoprotein Figure 3
IHC stain of HER-2 oncoprotein. Showing positive 
expression of HER-2 oncoprotein on carcinoma cell mem-
brane. (SP ×200).Cases Journal 2008, 1:285 http://www.casesjournal.com/content/1/1/285
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Recently, the genetic factors got more attention by scien-
tists [4,5]. The mutations of BRCA1, BRCA2 and MMR
gene may play very important roles in the onset of the
male breast cancer; and other genetic factors involved
could include AR gene, CHEK2 gene, cytochrome P45017
(CYP17), the XXY karyotype (Klinefelter syndrome), and
the PTEN tumor suppressor gene associated with Cowden
syndrome, and so on. The BRCA1 and BRCA2 germ-line
mutation is known associated with the hereditary breast
cancer [6]; and the MMR germ-line mutation (especially
hMLH1) for the hereditary nonpolyposis colorectal carci-
noma (HNPCC). Some researchers regarded the breast
cancer, especially the male breast cancer, as a part of the
tumor spectrum of HNPCC, and thought the breast cancer
might be an extracolonic manifestation of HNPCC [7].
Therefore, if a male patient with breast cancer is met with
in clinic, we should attend not only to examine the breast
focus, but also to inquire the patient about his family his-
tory and post history which is helpful for clinical diagno-
sis and therapy.
Occult breast cancer is even rarer in men. It usually
presents lymph node metastasis of axilla, supraclavicular
fossa and infraclavicular fossa as the first manifestation
[8]. In our case, the patient presented axillary lymph node
IHC stain of PCNA Figure 4
IHC stain of PCNA. Showing positive expression of PCNA 
in carcinoma cell nuclei. (SP ×200).
IHC stain of Bcl-2 oncoprotein Figure 5
IHC stain of Bcl-2 oncoprotein. Showing positive expres-
sion of Bcl-2 oncoprotein in carcinoma cell cytoplasm. (SP 
×200).
IHC stain of nm23 protein Figure 6
IHC stain of nm23 protein. Showing positive expression 
of nm23 protein in carcinoma cell cytoplasm. (SP ×200).
IHC stain of MRP Figure 7
IHC stain of MRP. Showing positive expression of MRP in 
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metastasis as the first manifestation. The most common
causes of axillary malignant lymph nodes include lym-
phoma and metastasis from breast cancer, lung cancer,
melanoma, and squamous cell cancer. So, we should give
our attention to take relevant examination to find focus
and avoid misdiagnosis, if we meet with similar patients
in clinic. Research shows that it is in approximately 50%
cases with occult breast cancer the cancer focus still can
not be found in the breast specimen [9]. In our case, no
tumor focus was found in breast specimen. The final diag-
nosis was made after many pathologists' consultation and
a series of examinations for differential diagnosis. Hereby,
the histological examination and IHC stain of metastasis
focus is very important in the diagnosis of the occult
breast cancer.
The currently recommended surgical therapy in clinic is
the modified radical mastectomy with axillary dissection.
It was reported that male breast carcinomas have a higher
positive rate of hormone receptor than the female breast
carcinomas, and so the adjuvant hormonal therapy is the-
oretically very promising [10]. In our case, although the
tumor cells were negative for ER and PR, the expression
results of PCNA, P53, Bcl-2, nm23, MRP and HER-2 pro-
tein were similar to other reports [1-4]. Because he was a
septuagenarian, his families did not agree with him to
undergo endocrine-therapy, chemotherapy and radiother-
apy after operation. But the patient's prognosis seems
well; he has survived with cancer-free for about 29
months after diagnosed, and he is still in follow-up.
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IHC stain of P53 protein Figure 8
IHC stain of P53 protein. Showing positive expression of 
P53 protein in carcinoma cell nuclei. (SP ×200).